»Go to related Japanese page in JPubb

Loading

Press Releases by "Daiichi Sankyo Company, Limited"


You may also like to check companies from Daiichi Sankyo Company, Limited's related industry or location as follows: Pharmaceuticals, Tokyo

« Previous12345Next »
1 - 50 of 246 for your search
Daiichi Sankyo Receives Approval for Additional Indication of Anticancer Agent Topotecin(R) Intravenous Drip Infusion
[ Pharmaceuticals | 2013-03-25]
Daiichi Sankyo Receives Approval in Japan for Manufacture and Marketing of PRALIA(R), a New Treatment for Osteoporosis
[ Pharmaceuticals | 2013-03-25]
Daiichi Sankyo Announces New 5-year Business Plan
[ Pharmaceuticals | 2013-03-22]
Daiichi Sankyo Appoints a New Executive Candidate for Domestic Subsidiary
[ Pharmaceuticals | 2013-03-18]
Daiichi Sankyo Announces Positive Phase 3 Study Results (PRASFIT-ACS) for Prasugrel in Japanese Patients with Acute Coronary Syndrome Undergoing PCI
[ Pharmaceuticals | 2013-03-16]
Daiichi Sankyo Announces Results of PRASFIT-Elective Study Regarding Use of Prasugrel in Elective Patients with Stable Angina and Chronic Myocardial Infarction Undergoing PCI
[ Pharmaceuticals | 2013-03-14]
Daiichi Sankyo to Facilitate New Drug Discovery in 2013 through Collaborative Research and Grants
[ Pharmaceuticals | 2013-03-06]
Daiichi Sankyo Appoints New Corporate Officers
[ Pharmaceuticals | 2013-03-04]
Daiichi Sankyo Announces Organizational Restructuring as of April 1, 2013
[ Pharmaceuticals | 2013-03-04]
Ranbaxy surpasses 2012 guidance; Crosses Rs.120 Bn in Global sales
[ Pharmaceuticals | 2013-02-27]
Announcement of application for approval in Japan of DPT-IPV vaccine for prevention of Diphtheria, Pertussis, Tetanus, and acute Poliomyelitis
[ Pharmaceuticals | 2013-02-20]
Daiichi Sankyo Announces Development of Nucleic Acid Treatment for Duchenne Muscular Dystrophy Utilizing Proprietary Technology
[ Pharmaceuticals | 2013-02-14]
DAIICHI SANKYO AND ARQULE ENROLL FIRST HEPATOCELLULAR CARCINOMA PATIENT INTO GLOBAL PHASE 3 TRIAL FOR TIVANTINIB
[ Pharmaceuticals | 2013-02-01]
Daiichi Sankyo and Ranbaxy to leverage synergies in Thailand
[ Pharmaceuticals | 2013-01-16]
DAIICHI SANKYO AND ARQULE ANNOUNCE TOP-LINE RESULTS OF PHASE 2 TRIAL WITH TIVANTINIB IN COLORECTAL CANCER
[ Pharmaceuticals | 2013-01-15]
Daiichi Sankyo and Amplimmune Announce Strategic Alliance to Develop AMP-110 Therapy for Autoimmune Disease
[ Pharmaceuticals | 2013-01-08]
Daiichi Sankyo Launches Alzheimer’s Disease Awareness Campaign New Treatments for the Disease are Gaining Popularity
[ Pharmaceuticals | 2012-12-20]
Daiichi Sankyo Espha to Launch New Generic Products
[ Pharmaceuticals | 2012-12-14]
Daiichi Sankyo Submits Application for Approval to Manufacture and Market Inavir(R) Dry Powder Inhaler, an Influenza Antiviral for the Prevention of Influenza in Japan
[ Pharmaceuticals | 2012-11-15]
Daiichi Sankyo Submits Application for Additional Indication of Anticancer Agent Topotecin(R) Intravenous Drip Infusion
[ Pharmaceuticals | 2012-11-09]
Ranbaxy delivers strong overall business performance; Improvement in base business sales and margins
[ Pharmaceuticals | 2012-11-09]
Daiichi Sankyo Selects Research Partners for TaNeDS Collaborative Drug Discovery Project
[ Pharmaceuticals | 2012-10-29]
Daiichi Sankyo Completes Enrolment in Hokusai-VTE, investigating once-daily Edoxaban in the Largest Single Phase 3 Study for the Treatment and Prevention of Recurrence of VTE
[ Pharmaceuticals | 2012-10-25]
Positive Phase 3 Study Results for Denosumab on Fracture Risk in Japanese Patients with Osteoporosis Presented at ASBMR
[ Pharmaceuticals | 2012-10-15]
ARQULE AND DAIICHI SANKYO ANNOUNCE DISCONTINUATION OF PHASE 3 MARQUEE CLINICAL TRIAL IN NON-SMALL CELL LUNG CANCER
[ Pharmaceuticals | 2012-10-02]
Daiichi Sankyo to Reorganize Japanese Supply Chain Subsidiaries and Integrate Odawara Plant
[ Pharmaceuticals | 2012-10-01]
Daiichi Sankyo Selected for Dow Jones Sustainability Asia Pacific Index for Third Consecutive Year
[ Pharmaceuticals | 2012-09-26]
Daiichi Sankyo Announces PRASFIT-ACS Results Regarding Prasugrel in Acute Coronary Syndrome Patients Undergoing PCI
[ Pharmaceuticals | 2012-09-21]
Kitasato Daiichi Sankyo Vaccine to Phase Out Animal Vaccine Business
[ Pharmaceuticals | 2012-09-18]
Launch of TENELIA(R) 20mg Tablets, A DPP-4 Inhibitor for Type 2 Diabetes Mellitus Originating from Japan
[ Pharmaceuticals | 2012-08-28]
Daiichi Sankyo and Lilly Announce TRILOGY ACS Results Regarding Effient(R) (Prasugrel) in Acute Coronary Syndrome UA/NSTEMI Patients to be Managed Medically without an Artery-Opening Procedure
[ Pharmaceuticals | 2012-08-26]
Positive Phase 3 Clinical Study Results for Inavir(R) Dry Powder Inhaler, an Influenza Antiviral, for the Prevention of Influenza
[ Pharmaceuticals | 2012-08-22]
Approval of Additional Indication of Ultrasound Contrast Agent SONAZOID(R) for Injection
[ Pharmaceuticals | 2012-08-10]
Ranbaxy returns sales growth of 55% in Q2 2012 with stronger profitability; receives approval for multiple value added, differentiated products
[ Pharmaceuticals | 2012-08-10]
About the News Report
[ Pharmaceuticals | 2012-07-23]
Daiichi Sankyo Selected for Japanese Government’s Second Initiative to Build Production Facilities for Biopharmaceuticals
[ Pharmaceuticals | 2012-07-12]
Notice on Details of the Share Options
[ Pharmaceuticals | 2012-07-09]
Notice about the Start of Business for Japan Vaccine
[ Pharmaceuticals | 2012-07-02]
Marketing and Manufacturing Approval Received for TENELIA(R) 20mg Tablets
[ Pharmaceuticals | 2012-06-29]
The Japan Research Foundation for Clinical Pharmacology, A Daiichi Sankyo Foundation, has awarded 5th Annual Clinical Pharmacology Research Award
[ Pharmaceuticals | 2012-06-29]
Daiichi Sankyo and Ranbaxy Launch Hybrid Business in Venezuela
[ Pharmaceuticals | 2012-06-20]
Tenth Takamine Memorial Daiichi Sankyo Prize Announced
[ Pharmaceuticals | 2012-06-13]
Daiichi Sankyo Launches Antihypertensive Agent Olmesartan in Mexico
[ Pharmaceuticals | 2012-06-11]
POSITIVE PHASE 2 STUDY RESULTS FOR TIVANTINIB IN PREVIOUSLY TREATED HEPATOCELLULAR CARCINOMA TO BE PRESENTED AT ASCO
[ Pharmaceuticals | 2012-06-04]
Daiichi Sankyo and the National Cancer Center Form Comprehensive Research Alliance
[ Pharmaceuticals | 2012-05-22]
ARQULE AND DAIICHI SANKYO ANNOUNCE COMPLETION OF PATIENT RECRUITMENT IN PHASE 3 CLINICAL TRIAL OF TIVANTINIB IN NON-SMALL CELL LUNG CANCER
[ Pharmaceuticals | 2012-05-21]
Ranbaxy sales grew over 55% with improvement in base business profitability
[ Pharmaceuticals | 2012-05-11]
Daiichi Sankyo Announces New Executive Candidates
[ Pharmaceuticals | 2012-05-11]
Daiichi Sankyo and Coherus Biosciences Establish Strategic Collaboration to Develop and Commercialize Biosimilar Candidates
[ Pharmaceuticals | 2012-05-08]
RANBAXY LAUNCHES SYNRIAM(TM) – INDIA’S FIRST NEW DRUG
[ Pharmaceuticals | 2012-04-26]
« Previous12345Next »



You may also like to check companies from Daiichi Sankyo Company, Limited's related industry or location as follows: Pharmaceuticals, Tokyo

Press Conferense Videos
Sharp and Semiconductor Energy Laboratory Jointly Develop New Oxide Semiconductor Technology That Will Revolutionize Displays Sharp and Semiconductor Energy Laboratory Jointly Develop New Oxide Semiconductor Technology That Will Revolutionize Displays
Sharp Corporation 2012/06/01
More Videos
Latest Press Release Search

Save favorite searches Hot keywords

Fukushima | power supply | cloud | solar
*NOTE: Recommended keywords shown above.
Your Most Recently Viewed Companies
Visit any of the company pages in JPubb, and your most recently viewed companies will automatically show up here.

Erase all This feature:ON How to use
Most Popular: Daiichi Sankyo Company, Limited
1. Daiichi Sankyo Head Office Consolidation in Tokyo
2011/10/07
Feed
Releases by Prefecture
Hokkaido | Aomori | Iwate | Miyagi | Akita | Yamagata | Fukushima

Ibaraki | Tochigi | Gunma | Saitama | Chiba | Tokyo | Kanagawa

Niigata | Toyama | Ishikawa | Fukui | Yamanashi | Nagano

Gifu | Shizuoka | Aichi | Mie

Shiga | Kyoto | Osaka | Hyogo | Nara | Wakayama

Tottori | Shimane | Okayama | Hiroshima | Yamaguchi

Tokushima | Kagawa | Ehime | Kochi

Fukuoka | Saga | Nagasaki | Kumamoto | Oita | Miyazaki | Kagoshima | Okinawa
Releases by Stock Exchange
TSE (Tokyo) All | TSE1 | TSE2 | Mothers

OSE (Osaka) All | OSE1 | OSE2 | JASDAQ Standard | JASDAQ Growth

NSE (Nagoya) All | NSE1 | NSE2 | Centrex | NSE-only

SSE (Sapporo) All | Ambitious | SSE-only

FSE (Fukuoka) All | Q-Board | FSE-only
Press Release Search
Company
Industry
Prefecture
Stock Exchange
Date
(yyyy/mm/dd)		 //～
//
Listed or Non-listed
*NOTE: Please input only items to be specified.
*NOTE: The "date" here means the one on which a press release is uploaded on this website. So it isn't necessarily the same as its official announcement date.
Company Search
Company
Industry
Prefecture
Stock Exchange
Listed or Non-listed
*NOTE: Please input only items to be specified.